50 Best Peptides

This website is for informational purposes only and does not constitute medical advice. Read disclaimer

#18

Semax

NeuroprotectiveMEHFPGPSemax Acetate

A synthetic analog of ACTH(4-10) developed in Russia as a neuroprotective and nootropic agent, approved there for stroke recovery, cognitive disorders, and peptic ulcer treatment.

Share:

Overview

Semax is a synthetic heptapeptide analog of the adrenocorticotropic hormone (ACTH) fragment 4-10, with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences (the same laboratory that developed Selank), Semax was designed to retain the neurotropic properties of ACTH while eliminating its hormonal (adrenal-stimulating) effects. The addition of the Pro-Gly-Pro C-terminal sequence improved metabolic stability.

Semax has been approved in Russia and Ukraine for several clinical indications, including treatment of stroke and its consequences, cognitive disorders, peptic ulcer disease, and enhancement of the body's adaptive capacity under extreme conditions. Russian military and space programs have reportedly used Semax to support cognitive performance under stress. Its approved status in these countries provides a body of clinical experience that, while not equivalent to Western regulatory standards, offers real-world safety and efficacy data.

The neuroprotective mechanisms of Semax are multifaceted. Research has shown it can increase BDNF and NGF (nerve growth factor) expression, protect neurons from oxidative stress, modulate serotonergic and dopaminergic systems, and support cerebral circulation. In stroke research, Semax has demonstrated the ability to reduce infarct size and improve functional recovery in animal models. Clinical studies in Russian stroke patients showed improvements in neurological outcomes when Semax was added to standard treatment protocols.

The nootropic effects of Semax are characterized by improvements in attention, memory, and learning capacity. Unlike stimulant-based cognitive enhancers, Semax appears to work through neurotrophic and neuromodulatory mechanisms rather than direct catecholamine stimulation. Users commonly report enhanced focus and mental clarity without jitteriness or anxiety. Variants including N-Acetyl Semax and N-Acetyl Semax Amidate have been developed with modifications aimed at improving potency and duration of action.

Research Uses & Applications

  • Approved in Russia for stroke recovery and cerebral circulation disorders
  • Cognitive enhancement and nootropic applications
  • Neuroprotection through BDNF and NGF upregulation
  • Performance optimization under stress conditions
  • Approved in Russia for peptic ulcer disease treatment
  • Research into neurodegenerative disease support

Key Research Findings

  • Russian clinical studies showed Semax improved neurological outcomes in stroke patients when added to standard treatment protocols.
  • Research demonstrated Semax increased BDNF expression in the hippocampus and cerebral cortex by 1.4 to 4.0 fold in animal models.
  • Studies showed neuroprotective effects against oxidative stress and glutamate excitotoxicity in neuronal cell cultures.
  • Clinical research in Russia documented improved attention, memory, and learning capacity in patients with cognitive disorders.
  • Animal studies demonstrated reduction in infarct size and improved behavioral recovery following experimental stroke.

Risks & Side Effects

  • Clinical evidence is primarily from Russian studies; Western regulatory-standard clinical trials are limited.
  • Hair loss has been occasionally reported, possibly related to BDNF modulation effects on hair follicles.
  • Irritability or emotional changes may occur in some individuals.
  • Nasal irritation with intranasal administration.
  • Optimal long-term dosing protocols for various applications are not well established in Western literature.

Administration

Most commonly administered as a nasal spray at doses of 200-600 mcg per nostril, 2-3 times daily. Subcutaneous injection is also used. In Russian clinical practice, treatment courses typically range from 10-14 days for acute conditions. Higher doses (up to 3 mg daily) have been used in stroke rehabilitation. N-Acetyl Semax variants may require lower doses due to enhanced potency.

Legal Status

Approved as a medication in Russia and Ukraine for multiple indications including stroke, cognitive disorders, and peptic ulcer disease. Not FDA-approved or EMA-approved. Available internationally as a research peptide. Not a controlled substance. The modified variants (N-Acetyl Semax, N-Acetyl Semax Amidate) are available from research peptide suppliers.

Frequently Asked Questions

What is Semax?

A synthetic analog of ACTH(4-10) developed in Russia as a neuroprotective and nootropic agent, approved there for stroke recovery, cognitive disorders, and peptic ulcer treatment.

What are the main uses of Semax?

The primary research applications of Semax include: Approved in Russia for stroke recovery and cerebral circulation disorders; Cognitive enhancement and nootropic applications; Neuroprotection through BDNF and NGF upregulation; Performance optimization under stress conditions; Approved in Russia for peptic ulcer disease treatment; Research into neurodegenerative disease support.

What are the risks and side effects of Semax?

Documented risks and side effects include: Clinical evidence is primarily from Russian studies; Western regulatory-standard clinical trials are limited.; Hair loss has been occasionally reported, possibly related to BDNF modulation effects on hair follicles.; Irritability or emotional changes may occur in some individuals.; Nasal irritation with intranasal administration.; Optimal long-term dosing protocols for various applications are not well established in Western literature.. Always consult a healthcare professional before considering any peptide.

Is Semax legal?

Approved as a medication in Russia and Ukraine for multiple indications including stroke, cognitive disorders, and peptic ulcer disease. Not FDA-approved or EMA-approved. Available internationally as a research peptide. Not a controlled substance. The modified variants (N-Acetyl Semax, N-Acetyl Semax Amidate) are available from research peptide suppliers.

How is Semax administered?

Most commonly administered as a nasal spray at doses of 200-600 mcg per nostril, 2-3 times daily. Subcutaneous injection is also used. In Russian clinical practice, treatment courses typically range from 10-14 days for acute conditions. Higher doses (up to 3 mg daily) have been used in stroke rehabilitation. N-Acetyl Semax variants may require lower doses due to enhanced potency.

Related Peptides

#17

Selank

Neuroprotective

#36

Cerebrolysin

Neuroprotective

#148

PACAP (Pituitary Adenylate Cyclase-Activating Peptide)

Neuroprotective

#19

LL-37

Immune Support

Stay Updated on Peptide Research

Get the latest peptide research news and updates delivered to your inbox.

Official Store

Experience Peptides on Your Skin

Shop our curated collection of peptide-infused skincare — Copper Peptide serums, anti-aging treatments, hydrogel patches, and more.

Shop Peptide Skincare

Important Disclaimer

The information on this page is for educational and informational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement. 50 Best Limited does not endorse, recommend, or promote the use of any peptide for self-administration. Read our full disclaimer.

← #17 Selank#19 LL-37 →